← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody (Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide (Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide)

Thymoma; Thymic Carcinoma · Thymoma

#Thymoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab, Cisplatin,5-Fluorouracil,Leucovorin (Cetuximab, Cisplatin,5-Fluorouracil,Leucovorin)

Stomach Neoplasms · Stomach Neoplasms

#StomachNeoplasms#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Irinotecan, Capecitabine (Cetuximab, Irinotecan, Capecitabine)

Rectal Neoplasms; Neoadjuvant Treatment · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab,Paclitaxel, Carboplatin (Cetuximab,Paclitaxel, Carboplatin)

Esophageal Cancer; Gastric Cancer · Esophageal Cancer

#EsophagealCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab,Paclitaxel,Cisplatin (Cetuximab,Paclitaxel,Cisplatin)

Oral Cancer · Oral Cancer

#OralCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab-IRDye800CW (Cetuximab-IRDye800CW)

Head and Neck Squamous Cell Carcinoma; Margin Assessment · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab-Zr. 89 (Cetuximab-Zr. 89)

Stage IV Cancer · Stage IV Cancer

#StageIVCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab/Gefitinib combination and/or monotherapy (Cetuximab/Gefitinib combination and/or monotherapy)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab/Gemcitabine (Cetuximab/Gemcitabine)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 3%임상시험 1상태 ACTIVE
AntibodystaleSun Yat-sen UniversityPhase 3

trastuzumab (Herceptin, Chemotherapy combined with trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 1

Cibisatamab (Cibisatamab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleCorvus Pharmaceuticals, Inc.Phase 1

atezolizumab (Tecentriq, Ciforadenant + atezolizumab)

Renal Cell Cancer; Metastatic Castration Resistant Prostate Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMerrimack PharmaceuticalsPhase 1

trastuzumab (Herceptin, Cisplatin, Capecitabine, Trastuzumab and MM-111)

HER-2 Gene Amplification · HER-2 Gene Amplification

#HER-2GeneAmplification#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleKing Faisal Specialist Hospital…Preclinical

trastuzumab (Herceptin, Cisplatin-Docetaxel ± Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Cisplatin/carboplatin and pemetrexed plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleImmunityBio, Inc.Phase 3

pembrolizumab (Keytruda, Cisplatin/carboplatin and pemetrexed plus pembrolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleGlaxoSmithKlinePhase 1

Cobolimab (Cobolimab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#항체#면역항체+2
효능 0%임상시험 1상태 ACTIVE

36 / 92 페이지

← 이전다음 →